Retmarker was distinguished with an Honourable Mention in the COTEC‐UNICER Award for Innovation Products – an event supported by the Expresso Newspaper. The 7th COTEC National Innovation Encounter was dedicated to the theme “The Innovator’s DNA” and took place on May 31^st in Estoril – Portugal.

See the english Press Release here or the portuguese version here.

Critical Health's is an approved Manufacturer of Medical Devices according to EC Directive 93/42/EEC Annex II, Article 3. The company's Quality Management System was certified by TÜV Rheinland according to EN ISO 13485:2003 + AC:2007 and EN ISO 9001:2008.

Retmarker was approved as Medical Device, entitled to display the CE 0197 mark.

See the english Press Release here or the portuguese version here.

Critical Health won an award at the European IT Excellence Awards in the category for Information Management, with one of its Retmarker product – Retmarker AMD. See the english Press Release here or the portuguese version here.

Critical Health has been judged to be a finalist at the European IT Excellence Awards 2010. The winner will be known at the gala awards dinner on 25th February 2010 at The Tower Hotel, London. With its brand new solution, RetmarkerAMD, Critical Health is among the four finalists in the ISV Category: Information Management.

At the PAAO/AAO Joint Meeting, Critical Health (Booth 4342-4344) showcases the RetmarkerDR, a Breakthrough in Predicting Diabetic Retinopathy Progression. See the press release here.

Critical Health Launches Innovative Diabetic Retinopathy Progression Biomarker Software Solution, RetmarkerDR, in the European Market at the 9th Euretina Congress (Booth C3; 14th to 17th May; Acropolis Centre; Nice;France).

Leading researchers from Critical Health’s partner AIBILI (Association for Biomedical Research and Innovation in Light and Image), will be presenting new research results that support this breakthrough in predicting Diabetic Retinopathy progression, also at the Euretina Congress. See the Press Release here.